Related content

Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease

By Cáceres-Redondo María   Carrillo Fátima   Lama María   Huertas-Fernández Ismael   Vargas-González Laura   Carballo Manuel   Mir Pablo  

Journal of Neurology, Vol. 261, Iss. 3, 2014-03 ,pp. : 561-569

Springer Publishing Company

Access to resources Recommend Favorite

A 10 year retrospective audit of long-term apomorphine use in Parkinson’s disease

By Tyne Hilary   Parsons Jan   Sinnott Ann   Fox Susan   Fletcher Nicholas   Steiger Malcolm  

Journal of Neurology, Vol. 251, Iss. 11, 2004-11 ,pp. : 1370-1374

Springer Publishing Company

Access to resources Recommend Favorite

Nachsorge nach tiefer Hirnstimulation bei Patienten mit M. Parkinson: Long-term care after deep brain stimulation of patients with Parkinson’s disease

By Sixel-Döring F.   Ebersbach G.  

Der Nervenarzt, Vol. 81, Iss. 6, 2010-06 ,pp. : 688-695

Springer Publishing Company

Access to resources Recommend Favorite

Therapy for dyskinesias in Parkinson’s disease patients

By Stefani Alessandro   Pierantozzi Mariangela   Koch Giacomo   Galati Salvatore   Stanzione Paolo  

Future Neurology, Vol. 5, Iss. 2, 2010-03 ,pp. : 277-299

Future Medicine

Access to resources Recommend Favorite

Dopamine receptor agonists in the therapy of Parkinson’s disease

By Foley P.   Gerlach M.   Double K. L.   Riederer P.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1375-1446

Springer Publishing Company

Access to resources Recommend Favorite